Terms: = Endocrine gland cancer AND uPA AND Treatment
80 results:
1. Validation of the Aldosteronoma Resolution Score as a Predictive Resolution Score of Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism in a North-African Population.
Saadi A; Bedoui MA; Zaghbib S; Boussaffa H; Mokaddem S; Nacef IB; Ayed H; Bouzouita A; Derouiche A; Khiari K; Chakroun M; Slama RB
World J Surg; 2023 Nov; 47(11):2776-2783. PubMed ID: 37667066
[TBL] [Abstract] [Full Text] [Related]
2. Predictors of successful outcome after adrenalectomy for unilateral primary aldosteronism.
Saadi A; Bedoui MA; Zaghbib S; Boussaffa H; Mokaddem S; Nacef IB; Ayed H; Derouiche A; Khiari K; Chakroun M; Ben Slama R
Front Endocrinol (Lausanne); 2023; 14():1205988. PubMed ID: 37635962
[TBL] [Abstract] [Full Text] [Related]
3. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study.
Evrard C; Ingrand P; Rochelle T; Martel M; Tachon G; Flores N; Randrian V; Ferru A; Haineaux PA; Goujon JM; Karayan-Tapon L; Tougeron D
Dig Liver Dis; 2023 Nov; 55(11):1562-1572. PubMed ID: 37308396
[TBL] [Abstract] [Full Text] [Related]
4. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
5. Urokinase plasminogen activator induces epithelial-mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-β axis, which is inhibited by 4-acetyl-antroquinonol B treatment.
Wu CZ; Chu YC; Lai SW; Hsieh MS; Yadav VK; Fong IH; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen JS
Phytomedicine; 2022 Jun; 100():154062. PubMed ID: 35366491
[TBL] [Abstract] [Full Text] [Related]
6. A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and cancer Cells Regulates Pancreatic cancer Metastasis.
Geng Y; Fan J; Chen L; Zhang C; Qu C; Qian L; Chen K; Meng Z; Chen Z; Wang P
Cancer Res; 2021 Jan; 81(1):64-76. PubMed ID: 33172931
[TBL] [Abstract] [Full Text] [Related]
7. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (upa) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
[TBL] [Abstract] [Full Text] [Related]
8. Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
Momeny M; Sabourinejad Z; Zarrinrad G; Moghaddaskho F; Eyvani H; Yousefi H; Mirshahvaladi S; Poursani EM; Barghi F; Poursheikhani A; Dardaei L; Bashash D; Ghazi-Khansari M; Tavangar SM; Dehpour AR; Yaghmaie M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Sci Rep; 2017 Apr; 7():45954. PubMed ID: 28383032
[TBL] [Abstract] [Full Text] [Related]
9. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.
Harris NLE; Vennin C; Conway JRW; Vine KL; Pinese M; Cowley MJ; Shearer RF; Lucas MC; Herrmann D; Allam AH; Pajic M; Morton JP; ; Biankin AV; Ranson M; Timpson P; Saunders DN
Oncogene; 2017 Jul; 36(30):4288-4298. PubMed ID: 28346421
[TBL] [Abstract] [Full Text] [Related]
10. RhoA/ROCK pathway mediates leptin-induced upa expression to promote cell invasion in ovarian cancer cells.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
[TBL] [Abstract] [Full Text] [Related]
11. Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?
van Dam PA; Coelho A; Rolfo C
Eur J Surg Oncol; 2017 Feb; 43(2):252-257. PubMed ID: 27345498
[TBL] [Abstract] [Full Text] [Related]
12. A novel upag-KPI fusion protein inhibits the growth and invasion of human ovarian cancer cells in vitro.
Zhao LP; Xu TM; Kan MJ; Xiao YC; Cui MH
Int J Mol Med; 2016 May; 37(5):1310-6. PubMed ID: 27035617
[TBL] [Abstract] [Full Text] [Related]
13. [All-trans retinoic acid improves iodine uptake of thyroid cancer cells via repressing transcriptional activity of β-catenin].
Lan L; Deng W; Chen HL; Huo LL; Deng LL; Zhang GY; Luo Y
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):553-8. PubMed ID: 26902198
[TBL] [Abstract] [Full Text] [Related]
14. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography.
Gurka MK; Pender D; Chuong P; Fouts BL; Sobelov A; McNally MW; Mezera M; Woo SY; McNally LR
J Control Release; 2016 Jun; 231():60-7. PubMed ID: 26763377
[TBL] [Abstract] [Full Text] [Related]
15. Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer.
Li W; Ma Z; Ma J; Li X; Xu Q; Duan W; Chen X; Lv Y; Zhou S; Wu E; Ma Q; Huo X
Oncotarget; 2015 Oct; 6(31):31119-33. PubMed ID: 26439801
[TBL] [Abstract] [Full Text] [Related]
16. Expression and activity analysis of a new fusion protein targeting ovarian cancer cells.
Su M; Chang W; Wang D; Cui M; Lin Y; Wu S; Xu T
Oncol Rep; 2015 Sep; 34(3):1337-44. PubMed ID: 26166362
[TBL] [Abstract] [Full Text] [Related]
17. Modulation of upa, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2015 Jul; 47(1):370-6. PubMed ID: 25997494
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
[TBL] [Abstract] [Full Text] [Related]
19. Expression and anticancer activity analysis of recombinant human upa1‑43-melittin.
Su M; Chang W; Cui M; Lin Y; Wu S; Xu T
Int J Oncol; 2015 Feb; 46(2):619-26. PubMed ID: 25394558
[TBL] [Abstract] [Full Text] [Related]
20. Up-regulation of urinary-type plasminogen activator correlates with high-risk papillary thyroid carcinoma with BRAF(V600E) mutation and its possible molecular mechanism.
Wakasa T; Li Y; Bai Y; Liu Z; Ozaki T; Mori I; Miyauchi A; Kakudo K; Nakamura M
Pathol Res Pract; 2014 Nov; 210(11):733-8. PubMed ID: 25085839
[TBL] [Abstract] [Full Text] [Related]
[Next]
